Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 7.98
-0.20 (-2.44%)
Oct 2, 2026, 2:08 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 173.73 million as of October 1, 2026. Its market cap has decreased by -19.56% in one year.
Market Cap
173.73M
Enterprise Value
179.41M
Revenue
9.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.98
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 173.73M, a decrease of -43.78%. That is a compound annual growth rate of -2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 173.73M | -63.51% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.07B |
| Idorsia | 1.25B |
| Basilea Pharmaceutica AG | 868.04M |
| Santhera Pharmaceuticals Holding AG | 237.45M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 127.17M |
| Xlife Sciences AG | 56.52M |
| MindMaze Therapeutics Holding | 25.06M |